Psychoactive phenethylamine drug
Pharmaceutical compound
Ariadne Clinical data Trade names Dimoxamine (tentative) Other names ARIADNE; 4-Methyl-2,5-dimethoxy-α-ethylphenethylamine; 2,5-Dimethoxy-4-methyl-α-ethylphenethylamine; 4C-D; 4C-DOM; "Four-carbon DOM"; α-Et-2C-D; α-Ethyl-2C-D; BL-3912; BL3912; Dimoxamine Routes of administration Oral [ 1] [ 2] Drug class Serotonin 5-HT2A ,5-HT2B , and5-HT2C receptor agonist ; Non-hallucinogenic serotonin 5-HT2A receptor agonist ;Antidepressant ;Stimulant ATC code Legal status Legal status Identifiers CAS Number PubChem CID ChemSpider UNII CompTox Dashboard (EPA) Chemical and physical data Formula C 13 H 21 N O 2 Molar mass 223.316 g·mol−1 3D model (JSmol ) InChI=1S/C13H21NO2/c1-5-11(14)7-10-8-12(15-3)9(2)6-13(10)16-4/h6,8,11H,5,7,14H2,1-4H3
Y Key:MLYCFWZIAJAIGW-UHFFFAOYSA-N
Y (verify)
Ariadne , also known chemically as4C-D or4C-DOM , by its developmental code nameBL-3912 , and by its former tentative brand nameDimoxamine , is apsychoactive drug of thephenethylamine ,phenylisobutylamine (α-ethylphenethylamine), and4C families.[ 3] [ 1] [ 2] [ 4] It is ananalogue of thepsychedelic drugs2C-D andDOM , with 2C-D having no substitution at theα carbon , DOM having an α-methyl group , and Ariadne having an α-ethyl group .[ 3] [ 1] [ 2] [ 4] Ariadne is takenorally .[ 1] [ 2]
The drug is aserotonin 5-HT2 receptor partial agonist , including of the serotonin5-HT2A receptor , similarly to psychedelics.[ 3] However, Ariadne is nothallucinogenic in humans, but is stillpsychoactive , producingantidepressant and mildstimulant effects such as feelings ofwell-being andmental alertness .[ 3] [ 1] [ 2] [ 5] The drug showsdopaminergic actions in animals, such asincreased motivation andreversal of parkinsonism , which may be mediated by serotonin 5-HT2A receptor activation-induceddopamine release in the brain.[ 3] [ 1] It is thought that the non-psychedelic nature of Ariadne with retained psychoactive effects is due to reduced but still highefficacy at the serotonin 5-HT2A receptor relative to psychedelics.[ 3]
Ariadne was firstsynthesized byAlexander Shulgin in 1968 and its psychoactive effects were discovered by Shulgin in 1969.[ 5] [ 3] [ 1] It was developed as a potentialpharmaceutical drug atBristol Laboratories , for instance as an antidepressant and for various other uses, and enteredclinical trials around 1974.[ 5] [ 3] [ 4] [ 2] The drug reachedphase 3 trials prior to its development being shelved.[ 5] The development of Ariadne is said to have been discontinued for strategic economic reasons rather than due to issues witheffectiveness orsafety .[ 5] [ 3] There has been renewed interest in Ariadne and similar drugs in the 2020s owing to increased interest in psychedelics for treatment ofpsychiatric disorders .[ 3] Ariadne is not an explicitlycontrolled substance in theUnited States .[ 2]
In his 1991 bookPiHKAL ,Alexander Shulgin reported human tests of Ariadne at doses of up to 32 mgorally , finding that it produced "the alert of a psychedelic, with none of the rest of the package".[ 1] Very little published data exists about the human pharmacology of Ariadne apart from Shulgin's limited testing; unpublished human trials reportedly observed somepsychoactive effects, but nohallucinations .[ 6] [ 3]
In his 2011 bookThe Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds , Shulgin described (R )-Ariadne as increasingmental alertness and producing feelings ofwell-being at doses of 25 to 50 mg orally.[ 2] It was claimed to improve symptoms ofmanic depression inpsychotic individuals at doses of 50 to 100 mg orally and to improve symptoms ofParkinson's disease at a dosage of 100 mg/day orally.[ 2] [ 3] Doses of up to 300 mg resulted in analtered state of consciousness but still no psychedelic effects.[ 3] [ 2] For comparison, DOM shows psychoactive sub-hallucinogenic effects at doses of 1 to 3 mg orally and psychedelic effects at doses of more than 3 mg orally.[ 3]
Ariadne, as the (R )-enantiomer , is active at doses as low as 25 mg and was tested inclinical trials at doses of 50 to 100 mg.[ 3] Doses as high as 300 mg have been assessed, more than 10 times higher than the minimum reported active dose.[ 3] No psychedelic effects occurred at this or lower doses, but therapeutic effects were observed.[ 3]
Ariadne activities Target Affinity (Ki , nM)5-HT1A >10,000 (Ki ) 656 (EC50 Tooltip half-maximal effective concentration ) 68% (Emax Tooltip maximal efficacy ) 5-HT1B >10,000 (Ki ) 4,023 (EC50 ) 90% ( Emax ) 5-HT1D ND (Ki ) 612 ( EC50 ) 65% ( Emax ) 5-HT1E ND (Ki ) 727 ( EC50 ) 79% ( Emax ) 5-HT1F ND (Ki ) 690 ( EC50 ) 75% ( Emax ) 5-HT2A 120 (Ki ) 39–1,300 (EC50 ) 80–91% ( Emax ) 5-HT2B >10,000 (Ki ) 217–>32,000 (EC50 ) 68–85% ( Emax ) 5-HT2C ND (Ki ) 120–582 ( EC50 ) 34–93% ( Emax ) 5-HT3 >10,000 5-HT4 ND (Ki ) ND ( EC50 ) <20% ( Emax ) 5-HT5A ND (Ki ) ND ( EC50 ) <20% ( Emax ) 5-HT6 ND (Ki ) 1,038 ( EC50 ) 42% ( Emax ) 5-HT7 ND (Ki ) ND ( EC50 ) <20% ( Emax ) α1A >10,000 α1B ,α1D ND α2A >10,000 α2B ,α2C ND β1 ,β2 >10,000 β3 ND D1 ,D2 >10,000 D3 –D5 ND H1 ,H2 >10,000 H3 ,H4 ND M1 –M3 >10,000 M4 ,M5 ND I1 ND σ1 ,σ2 ND TAAR1 Tooltip Trace amine-associated receptor 1 ND SERT Tooltip Serotonin transporter >10,000 (Ki ) >50,000 (IC50 Tooltip half-maximal inhibitory concentration )ND ( EC50 ) NET Tooltip Norepinephrine transporter >10,000 (Ki )ND ( IC50 ) ND ( EC50 ) DAT Tooltip Dopamine transporter >10,000 (Ki ) >100,000 (IC50 ) ND ( EC50 ) MAO-A Tooltip Monoamine oxidase A >10,000 (Ki ) Notes: The smaller the value, the more avidly the drug binds to the site. All proteins are human unless otherwise specified.Refs: [ 7] [ 3] [ 8]
Ariadne is apotent andselective agonist of theserotonin 5-HT2 receptors , including of the serotonin5-HT2A ,5-HT2B , and5-HT2C receptors .[ 3] [ 8] However, it is lessefficacious in activating the serotonin 5-HT2A receptor, including theGq , G11 , andβ-arrestin2 signaling pathways, compared to the related drugDOM , and this weakerpartial agonism may be responsible for its lack of psychedelic effects.[ 3] [ 8] In addition to the serotonin 5-HT2 receptors, Ariadne is a lower-affinity agonist of the serotonin5-HT1 receptors .[ 3] Ariadne shows essentially no activity at themonoamine transporters .[ 3]
Ariadne shows a markedly attenuatedhead-twitch response , a behavioral proxy of psychedelic effects, in animals, although it does still significantly induce a weak head-twitch response.[ 3] [ 8] [ 9] The drug substitutes for DOM in rodentdrug discrimination tests, albeit with dramatically lowerpotency thanDOx drugs like DOM itself,DOET , andDOB .[ 9] It has also been shown to produce stimulus generalization in rats trained to respond toLSD [ 6] andMDMA .[ 10] Ariadne's capacity to fully substitute for MDMA is not shared with DOM and is unusual among psychedelics, but is shared withα-ethyltryptamine (αET).[ 10] [ 11] In monkeys, Ariadne was found to possiblyincrease motivation , as it caused monkeys that had stopped running mazes to begin running them again.[ 1] Ariadne has also been found to be effective in ananimal model ofParkinson's disease , where it reversedmotor deficits similarly tolevodopa .[ 3]
Serotonin 5-HT2A receptor agonists have been found to increasedopamine levels in thenucleus accumbens and othermesolimbic areas .[ 3] Non-hallucinogenic serotonin 5-HT2A receptor agonists like Ariadne may produce this effect without causing psychedelic effects.[ 3] This action may underlie the preliminary observations of effectiveness of Ariadne in the treatment ofparkinsonism in animals and humans.[ 3]
Ariadne, also known as 4-methyl-2,5-dimethoxy-α-ethylphenethylamine, is asubstituted phenethylamine andamphetamine derivative .[ 1] [ 2] It is theanalogue of2,5-dimethoxy-4-methylamphetamine (DOM) in which theα -methyl group has been replaced with an α-ethyl group and is the analogue of2,5-dimethoxy-4-methylphenethylamine (2C-D) with an ethyl group substituted at the α carbon.[ 3] [ 1] [ 2]
Thechemical synthesis of Ariadne has been described.[ 1] [ 2]
Other related compounds include the4C derivatives4C-B (the α-ethyl homologue of2C-B andDOB ) and4C-T-2 (the α-ethyl homologue of2C-T-2 andAleph-2 ) among others.[ 1] [ 12] [ 3] Unlike Ariadne, 4C-B has been reported to produce pronounced psychedelic effects, although generally milder than those of 2C-B or DOB.[ 12]
Ariadne was firstsynthesized byAlexander Shulgin in 1968 and he discovered itspsychoactive effects in 1969.[ 5] [ 3] [ 1] Shulgin reported that the drug was tested byBristol Laboratories as anantidepressant , in an anecdote where he was explaining how human testing is invaluable (compared to animal testing) on drugs that change the state of the mind. He said, "Before they launched into a full multi-clinic study to determine whether it's going to be worth the animal studies or not, every person on the board of directors took it."[ 4] InThe Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds (2011), he described it also being evaluated for increasingmental alertness ingeriatric individuals, treatingParkinson's disease , and treatingpsychosis andmanic depression .[ 2] [ 3] The tentative commercial name of Ariadne wasDimoxamine .[ 2] (R )-Ariadne was said to have completedphase 2 clinical trials and to have reachedphase 3 trials, but the actual clinical data were never disclosed and further development was halted due to strategic economic reasons.[ 5] [ 3] However, according to journalistHamilton Morris , the United StatesCentral Intelligence Agency (CIA) may have had involvement in the discontinuation of Ariadne's development.[ 13]
Society and culture [ edit ] Ariadne's alternative name4C-DOM or4C-D stands for "four-carbon DOM", whereas the name of 2C-D stands for "two-carbon DOM".[ 3] Another name of Ariadne isα-Et-2C-D , which stands for α-ethyl-2C-D.[ 9] Racemic Ariadne is additionally known by the former developmental code nameBL-3912 , while the (R )-enantiomer of Ariadne (R )-Ariadne, is known by the former developmental code nameBL-3912A .[ 3] [ 2]
Ariadne is not an explicitlycontrolled substance anywhere in theUnited States as of 2011.[ 2]
^a b c d e f g h i j k l m n Alexander T. Shulgin ,Ann Shulgin (1991)."#8 ARIADNE; 4C-DOM; BL-3912; DIMOXAMINE; 1-(2,5- DIMETHOXY-4-METHYLPHENYL)-2-AMINOBUTANE; 2,5- DIMETHOXY-a-ETHYL-4-METHYLPHENETHYLAMINE" .PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press. pp. 475– 480.ISBN 978-0-9630096-0-9 .OCLC 25627628 .^a b c d e f g h i j k l m n o p q r Shulgin A, Manning T, Daley PF (2011)."#7. ARIADNE" .The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds . Vol. 1. Berkeley, CA: Transform Press. pp. 7– 9.ISBN 978-0-9630096-3-0 .OCLC 709667010 .It was developed commercially by the Bristol-Myers Company to increase mental alertness in geriatric patients, and was patented in Germany, France, and the United States (Shulgin, 1974a, 1974b, 1977a). Its commercial name, Dimoxamine, does not have a classic female ring to it. [...] In normal human subjects, R-4C-DOM orally at 25—50 mg increased mental alertness and feelings of well-being. At 100 mg/day, the symptoms of Parkinson's disease went into remission. With psychotic patients there was a consistent relief of manic depression at doses of 50-100 mg (Shulgin, 1977a; Partyka et al., 1978). A single human oral ingestion of 270 mg produced a change of state of consciousness but evoked no psychedelic effects (Winter, 1980). ^a b c d e f g h i j k l m n o p q r s t u v w x y z aa ab ac ad ae af ag ah Cunningham MJ, Bock HA, Serrano IC, Bechand B, Vidyadhara DJ, Bonniwell EM, et al. (January 2023)."Pharmacological Mechanism of the Non-hallucinogenic 5-HT2A Agonist Ariadne and Analogs" .ACS Chemical Neuroscience .14 (1):119– 135.doi :10.1021/acschemneuro.2c00597 .PMC 10147382 .PMID 36521179 . ^a b c d Shulgin A (2021).The Nature of Drugs . Berkeley, California: Transform Press. pp. 299– 300.ISBN 978-0-9995472-1-2 . ^a b c d e f g Shulgin AT (1987)."The "Social-Chemistry" of Pharmacological Discovery: Interview with Dr. Alexander T. Shulgin. January 26, 1986" .Social Pharmacology .1 (3):279– 290. ^a b Winter JC (1980-05-01). "Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus".Psychopharmacology .68 (2):159– 162.doi :10.1007/BF00432134 .PMID 6776559 .S2CID 12221170 . ^ Sharp T, Ippolito A (May 2025)."Neuropsychopharmacology of hallucinogenic and non-hallucinogenic 5-HT2A receptor agonists" .Br J Pharmacol .doi :10.1111/bph.70050 .PMID 40405723 . ^a b c d Wallach J, Cao AB, Calkins MM, Heim AJ, Lanham JK, Bonniwell EM, et al. (December 2023)."Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential" .Nat Commun .14 (1): 8221.doi :10.1038/s41467-023-44016-1 .PMC 10724237 .PMID 38102107 . ^a b c Halberstadt AL, Chatha M, Klein AK, Wallach J, Brandt SD (May 2020)."Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species" .Neuropharmacology .167 107933.doi :10.1016/j.neuropharm.2019.107933 .PMC 9191653 .PMID 31917152 . ^a b Glennon RA (October 1993). "MDMA-like stimulus effects of alpha-ethyltryptamine and the alpha-ethyl homolog of DOM".Pharmacology, Biochemistry, and Behavior .46 (2):459– 462.doi :10.1016/0091-3057(93)90379-8 .PMID 7903460 .S2CID 54356633 . ^ Oberlender RA (May 1989)."Stereoselective aspects of hallucinogenic drug action and drug discrimination studies of entactogens" .Purdue e-Pubs . Purdue University.The results of initial studies (Nichols et al., 1986) generally demonstrated the lack of LSD-Iike discriminative stimulus properties for the members of the entactogen drug class. This was confirmed and extended to other hallucinogens in tests with rats trained on entactogens. These results are summarized in Table 12. Table 12. Results of DD tests comparing entactogens and hallucinogens. [...] It seems clear that entactogen activity is distinct from that of hallucinogens. [...] ^a b Trachsel D, Lehmann D, Enzensperger C (2013).Phenethylamine: Von der Struktur zur Funktion . Nachtschatten Verlag AG. p. 832.ISBN 978-3-03788-700-4 .Das α-Ethylhomologon von 2C-B (6) trägt den Namen (303; auch 4C-B) und wurde von Rausch eingehender untersucht [140, 145]. Es vermochte eine ausgeprägte psychedelische Wirkung mit Bewusstseinsvertiefung, Euphorie und Sensationen besonders im Bereich des Tastsinns hervorzurufen (50—80mg, rund acht Stunden Wirkdauer). Visuelle Pseudohalluzinationen traten kaum auf. Das Iodoanalogon DOI-B (304) wurde nur bis zu einer Dosierung von 4mg geprüft und zeigte dabei keinerlei Wirkungen [8]. ^ Smith S (25 September 2025)."The Hidden Side of Psychedelic Research ft. Hamilton Morris" .YouTube .Vice News . Retrieved29 September 2025 .
Tryptamines
No ring subs. 4-Hydroxytryptamines 5-Hydroxytryptamines 5-Methoxytryptamines Other ring subs. α-Alkyltryptamines Others Cyclized Ergolines /lysergamides (e.g.,LSD )β-Carbolines andHarmala alkaloids (e.g.,harmine ,harmaline ,6-methoxyharmalan )Iboga alkaloids (e.g.,18-MAC ,18-MC ,coronaridine ,ibogaine ,ibogamine ,ME-18-MC ,noribogaine ,tabernanthine ,voacangine )Ibogalogs (e.g.,ibogainalog )O -MethylnordehydrobufoteninePartial ergolines (e.g.,NDTDI ,RU-28306 ,CT-5252 )Piperidinylethylindoles (e.g.,pip-T )Pyrrolidinylethylindoles (e.g.,pyr-T ,5-MeO-pyr-T )Pyrrolidinylmethylindoles (e.g.,MPMI ,4-HO-MPMI (lucigenol) ,5-MeO-MPMI )Tetrahydropyridinylindoles (e.g.,RU-28253 (5-MeO-THPI) ,NEtPhOH-THPI )Bioisosteres Benzofurans (e.g.,5-MeO-DiBF ,dimemebfe (5-MeO-BFE) ,mebfap )Benzothiophenes (e.g.,3-APBT )Indazolethylamines (e.g.,AL-38022A ,O -methyl-AL-34662 )Indenylethylamines (e.g.,C-DMT )Isotryptamines (e.g.,6-MeO-isoDMT ,Ro60-0175 )MYCO-005 Quinolinylethylamines (e.g.,mefloquine )
Phenethylamines
Scalines 2C-x Others: 2C-B-AN 2C-DB 2C-G-x (e.g.,2C-G-3 ,2C-G-5 )β-Keto-2C-B (βk-2C-B) β-Keto-2C-I (βk-2C-I) β-Methyl-2C-B (BMB) BOx (e.g.,BOB ,BOD ,BOH-2C-B )HOT-x (e.g.,HOT-2 ,HOT-7 ,HOT-17 )N -Ethyl-2C-BTWEETIOs (e.g.,2CD-2-ETO ,2CD-5-ETO ,2CE-5-ETO ,2CE-5iPrO ,2CT2-5-ETO ,ASR-2001 (2CB-5PrO) )3C-x DOx 4C-x Ψ-PEA MDxx FLY 25x-NB (NBOMes) Others 2-TOET 2-TOM 25B-NAcPip 4-HA 5-TOET 5-TOM Benzofurans (e.g.,5-APB ,5-APDB ,6-APB ,6-APDB ,F ,F-2 ,F-22 )Benzothiophenes (e.g.,5-APBT ,6-APBT )CT-5172 DMAs (e.g.,2,4-DMA ,3,4-DMA )Fenfluramine MMA (3-MeO-4-MA) Norfenfluramine PEA-NDEPAs (e.g.,25D-NM-NDEAOP ,DOB-NDEPA ,DOI-NDEPA ,DOM-NDEPA ,DOTFM-NDEPA ,M-NDEPA ,TMA-2-NDEPA )PMA (4-MA) TMAs (e.g.,TMA-3 ,TMA-4 ,TMA-5 )TOMSO ZDCM-04 Cyclized 1-Aminomethylindanes (e.g.,2CB-Ind ,jimscaline )2-Aminoindanes (e.g.,DOM-AI )3-Benzazepines (e.g.,lorcaserin )3-Phenylpiperidines (e.g.,LPH-5 ,LPH-48 )Benzocyclobutenes (e.g.,2CBCB-NBOMe ,TCB-2 ,tomscaline )Benzoxepins (e.g.,BBOX ,IBOX ,TFMBOX )DMBMPP (juncosamine) Ergolines /lysergamides (e.g.,LSD )Glaucine Partial ergolines (e.g.,NDTDI ,DEIMDHPCA ,DEMPDHPCA ,DEMTMPDHPCA ,DEMNDHPCA )Phenylcyclopropylamines (e.g.,DMCPA ,TMT )Phenyloxazolamines (aminorexes ) (e.g.,2C-B-aminorex )Pyridopyrroloquinoxalines (e.g.,IHCH-7113 )Z3517967757 ZC-B
Lysergamides Others Arylpiperazines (e.g.,2C-B-PP ,2-NP ,mCPP ,MK-212 ,ORG-12962 ,pCPP ,pFPP ,quipazine ,TFMPP )Dihydrobenzoxazines (e.g.,efavirenz )Phenoxyethylamines (e.g.,CT-4719 ,ORG-37684 )Pyridopyrroloquinoxalines (e.g.,IHCH-7113 )Quinazolinylethylamines (e.g.,RH-34 )Natural sources Tryptamines: Acacia spp. (e.g.,Acacia acuminata ,Acacia confusa )Ayahuasca andvinho de Jurema (e.g.,Psychotria viridis (chacruna) ,Dipolopterys cabrerana (chaliponga, chacruna) ,Mimosa tenuiflora (Mimosa hostilis ; jurema) )Brosimum (e.g.,Brosimum acutifolium (takini) )Hallucinogenic snuffs (e.g.,Anadenanthera peregrina (yopo, jopo, cohoba, parica, ebene) ,Anadenanthera colubrina (vilca, cebil) )Incilius alvarius (Bufo alvarius ; Colorado River toad, Sonoran Desert toad; bufo)Psilocybin-containing mushrooms (magic mushrooms, shrooms) (e.g.,Psilocybe cubensis ,Psilocybe mexicana (teonanacatl) )Lysergamides: Achnatherum robustum (sleepy grass)Epichloë spp.Ergot (Claviceps ) (e.g.,Claviceps purpurea ,Claviceps paspali )Morning glory (Convolvulaceae) seeds (e.g.,Ipomoea tricolor (tlitliltzin, badoh negro;Ipomoea violacea ) ,Ipomoea corymbosa (coaxihuitl, ololiúqui;Rivea Corymbosa ,Turbina Corymbosa ) ,Argyreia nervosa (Hawaiian baby woodrose; HBWR) )Periglandula spp. (e.g.,Periglandula ipomoeae ,Periglandula clandestina )
5-HT1
5-HT1A
Agonists: 4-F-5-MeO-pyr-T 5-MeO-pip-T 5-MeO-pyr-T 8-OH-DPAT Adatanserin Amphetamine Antidepressants (e.g.,etoperidone ,hydroxynefazodone ,nefazodone ,trazodone ,triazoledione ,vilazodone ,vortioxetine )Atypical antipsychotics (e.g.,aripiprazole ,asenapine ,brexpiprazole ,cariprazine ,clozapine ,lurasidone ,quetiapine ,ziprasidone )Azapirones (e.g.,buspirone ,eptapirone ,gepirone ,perospirone ,tandospirone )Bay R 1531 Befiradol BMY-14802 Cannabidiol Dimemebfe Dopamine Ebalzotan Eltoprazine Enciprazine Ergolines (e.g.,bromocriptine ,cabergoline ,dihydroergotamine ,ergotamine ,lisuride ,LSD ,methylergometrine (methylergonovine) ,methysergide ,pergolide )F-11461 F-12826 F-13714 F-14679 F-15063 F-15599 Flesinoxan Flibanserin Flumexadol Hypidone Lesopitron LY-293284 LY-301317 mCPP MKC-242 Naluzotan NBUMP Osemozotan Oxaflozane Pardoprunox Piclozotan Rauwolscine Repinotan Roxindole RU-24969 S-14506 S-14671 S-15535 Sarizotan Serotonin (5-HT) SSR-181507 Sunepitron Tryptamines (e.g.,5-CT ,5-MeO-DMT ,5-MT ,bufotenin ,DMT ,indorenate ,N-Me-5-HT ,psilocin ,psilocybin )TGBA01AD TMU4142 U-92016-A Urapidil Vilazodone Xaliproden Yohimbine Antagonists: Atypical antipsychotics (e.g.,iloperidone ,risperidone ,sertindole )AV965 Beta blockers (e.g.,alprenolol ,carteolol ,cyanopindolol ,iodocyanopindolol ,isamoltane ,oxprenolol ,penbutolol ,pindobind ,pindolol ,propranolol ,tertatolol )BMY-7378 CSP-2503 Dotarizine Ergolines (e.g.,metergoline )FCE-24379 Flopropione GR-46611 Isamoltane Lecozotan Mefway Metitepine (methiothepin) MIN-117 (WF-516) MPPF NAN-190 Robalzotan S-15535 SB-649915 SDZ 216-525 Spiperone Spiramide Spiroxatrine UH-301 WAY-100135 WAY-100635 Xylamidine
5-HT1B
Agonists: Anpirtoline AZ10419369 Benzofurans (e.g.,5-MAPB ,6-MAPB ,BK-5-MAPB ,BK-6-MAPB )Benzothiophenes (e.g.,5-MAPBT ,6-MAPBT ,BK-5-MAPBT )CGS-12066A CP-93129 CP-94253 CP-122288 CP-135807 Eltoprazine Ergolines (e.g.,bromocriptine ,dihydroergotamine ,ergotamine ,methylergometrine (methylergonovine) ,methysergide ,pergolide )mCPP Methylenedioxyphenethylamines (e.g.,MDMA ,methylone )PZKKN-94 RU-24969 Serotonin (5-HT) Triptans (e.g.,avitriptan ,donitriptan ,eletriptan ,sumatriptan ,zolmitriptan )TFMPP Tryptamines (e.g.,5-BT ,5-CT ,5-MT ,DMT )Vortioxetine
5-HT1D
Agonists: CP-122288 CP-135807 CP-286601 Ergolines (e.g.,bromocriptine ,cabergoline ,dihydroergotamine ,ergotamine ,LSD ,methysergide )GR-46611 L-694247 L-772405 mCPP PNU-109291 PNU-142633 Serotonin (5-HT) TGBA01AD Triptans (e.g.,almotriptan ,avitriptan ,donitriptan ,eletriptan ,frovatriptan ,naratriptan ,rizatriptan ,sumatriptan ,zolmitriptan )Tryptamines (e.g.,5-BT ,5-CT ,5-Et-DMT ,5-MT ,5-(nonyloxy)tryptamine ,DMT )
5-HT1E
5-HT1F
5-HT2
5-HT2A
Agonists: 25H/NB series (e.g.,25I-NBF ,25I-NBMD ,25I-NBOH ,25I-NBOMe ,25B-NBOMe ,25C-NBOMe ,25TFM-NBOMe ,2CBCB-NBOMe ,25CN-NBOH ,2CBFly-NBOMe )2Cs (e.g.,2C-B ,2C-E ,2C-I ,2C-T-2 ,2C-T-7 ,2C-T-21 )2C-B-FLY 2CB-Ind 5-Methoxytryptamines (5-MeO-DET ,5-MeO-DiPT ,5-MeO-DMT ,5-MeO-DPT ,5-MT )α-Alkyltryptamines (e.g.,5-Cl-αMT ,5-Fl-αMT ,5-MeO-αET ,5-MeO-αMT ,α-Me-5-HT ,αET ,αMT )AL-34662 AL-37350A Bromo-DragonFLY Dimemebfe DMBMPP DOx (e.g.,DOB ,DOC ,DOI ,DOM )Efavirenz Ergolines (e.g.,1P-LSD ,ALD-52 ,bromocriptine ,cabergoline ,ergine (LSA) ,ergometrine (ergonovine) ,ergotamine ,lisuride ,LA-SS-Az ,LSB ,LSD ,LSD-Pip ,LSH ,LSP ,methylergometrine (methylergonovine) ,pergolide )Flumexadol IHCH-7113 Jimscaline Lorcaserin MDxx (e.g.,MDA (tenamfetamine) ,MDMA (midomafetamine) ,MDOH ,MMDA )O-4310 Oxaflozane PHA-57378 PNU-22394 PNU-181731 RH-34 SCHEMBL5334361 Phenethylamines (e.g.,lophophine ,mescaline )Piperazines (e.g.,BZP ,quipazine ,TFMPP )Serotonin (5-HT) TCB-2 TFMFly Tryptamines (e.g.,5-BT ,5-CT ,bufotenin ,DET ,DiPT ,DMT ,DPT ,psilocin ,psilocybin ,tryptamine )Antagonists: 5-I-R91150 5-MeO-NBpBrT AC-90179 Adatanserin Altanserin Antihistamines (e.g.,cyproheptadine ,hydroxyzine ,ketotifen ,perlapine )AMDA Atypical antipsychotics (e.g.,amperozide ,aripiprazole ,asenapine ,blonanserin ,brexpiprazole ,carpipramine ,clocapramine ,clorotepine ,clozapine ,fluperlapine ,gevotroline ,iloperidone ,lurasidone ,melperone ,mosapramine ,ocaperidone ,olanzapine ,paliperidone ,quetiapine ,risperidone ,sertindole ,zicronapine ,ziprasidone ,zotepine )Chlorprothixene Cinanserin CSP-2503 Deramciclane Dotarizine Eplivanserin Ergolines (e.g.,amesergide ,LY-53857 ,LY-215840 ,mesulergine ,metergoline ,methysergide ,sergolexole )Fananserin Flibanserin Glemanserin Irindalone Ketanserin KML-010 Landipirdine LY-393558 mCPP Medifoxamine Metitepine (methiothepin) MIN-117 (WF-516) Naftidrofuryl Nantenine Nelotanserin Opiranserin (VVZ-149) Pelanserin Phenoxybenzamine Pimavanserin Pirenperone Pizotifen Pruvanserin Rauwolscine Ritanserin Roluperidone S-14671 Sarpogrelate Serotonin antagonists and reuptake inhibitors (e.g.,etoperidone ,hydroxynefazodone ,lubazodone ,mepiprazole ,nefazodone ,triazoledione ,trazodone )SR-46349B TGBA01AD Teniloxazine Temanogrel Tetracyclic antidepressants (e.g.,amoxapine ,aptazapine ,esmirtazapine ,maprotiline ,mianserin ,mirtazapine )Tricyclic antidepressants (e.g.,amitriptyline )Typical antipsychotics (e.g.,chlorpromazine ,fluphenazine ,haloperidol ,loxapine ,perphenazine ,pimozide ,pipamperone ,prochlorperazine ,setoperone ,spiperone ,spiramide ,thioridazine ,thiothixene ,trifluoperazine )Volinanserin Xylamidine Yohimbine
5-HT2B
Agonists: 4-Methylaminorex Aminorex Amphetamines (e.g.,chlorphentermine ,cloforex ,dexfenfluramine ,fenfluramine ,levofenfluramine ,norfenfluramine )BW-723C86 DOx (e.g.,DOB ,DOC ,DOI ,DOM )Ergolines (e.g.,cabergoline ,dihydroergocryptine ,dihydroergotamine ,ergotamine ,methylergometrine (methylergonovine) ,methysergide ,pergolide )Lorcaserin MDxx (e.g.,MDA (tenamfetamine) ,MDMA (midomafetamine) ,MDOH ,MMDA )Piperazines (e.g.,TFMPP )PNU-22394 Ro60-0175 Serotonin (5-HT) Tryptamines (e.g.,5-BT ,5-CT ,5-MT ,α-Me-5-HT ,bufotenin ,DET ,DiPT ,DMT ,DPT ,psilocin ,psilocybin ,tryptamine )Antagonists: Agomelatine Atypical antipsychotics (e.g.,amisulpride ,aripiprazole ,asenapine ,brexpiprazole ,cariprazine ,clozapine ,N-desalkylquetiapine (norquetiapine) ,N-desmethylclozapine (norclozapine) ,olanzapine ,pipamperone ,quetiapine ,risperidone ,ziprasidone )Cyproheptadine EGIS-7625 Ergolines (e.g.,amesergide ,bromocriptine ,lisuride ,LY-53857 ,LY-272015 ,mesulergine )Ketanserin LY-393558 mCPP Metadoxine Metitepine (methiothepin) Pirenperone Pizotifen Propranolol PRX-08066 Rauwolscine Ritanserin RS-127445 Sarpogrelate SB-200646 SB-204741 SB-206553 SB-215505 SB-221284 SB-228357 SDZ SER-082 Tegaserod Tetracyclic antidepressants (e.g.,amoxapine ,mianserin ,mirtazapine )Trazodone Typical antipsychotics (e.g.,chlorpromazine )TIK-301 Yohimbine
5-HT2C
Agonists: 2Cs (e.g.,2C-B ,2C-E ,2C-I ,2C-T-2 ,2C-T-7 ,2C-T-21 )5-Methoxytryptamines (5-MeO-DET ,5-MeO-DiPT ,5-MeO-DMT ,5-MeO-DPT ,5-MT )α-Alkyltryptamines (e.g.,5-Cl-αMT ,5-Fl-αMT ,5-MeO-αET ,5-MeO-αMT ,α-Me-5-HT ,αET ,αMT )A-372159 AL-38022A Alstonine CP-809101 Dimemebfe DOx (e.g.,DOB ,DOC ,DOI ,DOM )Ergolines (e.g.,ALD-52 ,cabergoline ,dihydroergotamine ,ergine (LSA) ,ergotamine ,lisuride ,LA-SS-Az ,LSB ,LSD ,LSD-Pip ,LSH ,LSP ,pergolide )Flumexadol Lorcaserin MDxx (e.g.,MDA (tenamfetamine) ,MDMA (midomafetamine) ,MDOH ,MMDA )MK-212 ORG-12962 ORG-37684 Oxaflozane PHA-57378 Phenethylamines (e.g.,lophophine ,mescaline )Piperazines (e.g.,aripiprazole ,BZP ,mCPP ,quipazine ,TFMPP )PNU-22394 PNU-181731 Ro60-0175 Ro60-0213 Serotonin (5-HT) Tryptamines (e.g.,5-BT ,5-CT ,bufotenin ,DET ,DiPT ,DMT ,DPT ,psilocin ,psilocybin ,tryptamine )Vabicaserin WAY-629 WAY-161503 YM-348 Antagonists: Adatanserin Agomelatine Atypical antipsychotics (e.g.,asenapine ,clorotepine ,clozapine ,fluperlapine ,iloperidone ,melperone ,olanzapine ,paliperidone ,quetiapine ,risperidone ,sertindole ,ziprasidone ,zotepine )Captodiame CEPC Cinanserin Cyproheptadine Deramciclane Desmetramadol Dotarizine Eltoprazine Ergolines (e.g.,amesergide ,bromocriptine ,LY-53857 ,LY-215840 ,mesulergine ,metergoline ,methysergide ,sergolexole )Etoperidone Fluoxetine FR-260010 Irindalone Ketanserin Ketotifen Latrepirdine (dimebolin) Medifoxamine Metitepine (methiothepin) Nefazodone Pirenperone Pizotifen Propranolol Ritanserin RS-102221 S-14671 SB-200646 SB-206553 SB-221284 SB-228357 SB-242084 SB-243213 SDZ SER-082 Tedatioxetine Tetracyclic antidepressants (e.g.,amoxapine ,aptazapine ,esmirtazapine ,maprotiline ,mianserin ,mirtazapine )TIK-301 Tramadol Trazodone Tricyclic antidepressants (e.g.,amitriptyline ,nortriptyline )Typical antipsychotics (e.g.,chlorpromazine ,loxapine ,pimozide ,pipamperone ,thioridazine )Xylamidine
5-HT3 –7
5-HT3
Agonists: Alcohols (e.g.,butanol ,ethanol (alcohol) ,trichloroethanol )m-CPBG Phenylbiguanide Piperazines (e.g.,BZP ,mCPP ,quipazine )RS-56812 Serotonin (5-HT) SR-57227 SR-57227A Tryptamines (e.g.,2-Me-5-HT ,5-CT ,bufotenidine (5-HTQ) )Volatiles/gases (e.g.,halothane ,isoflurane ,toluene ,trichloroethane )YM-31636 Antagonists: Alosetron Anpirtoline Arazasetron AS-8112 Atypical antipsychotics (e.g.,clozapine ,olanzapine ,quetiapine )Azasetron Batanopride Bemesetron (MDL-72222) Cilansetron CSP-2503 Dazopride Dolasetron Galanolactone Granisetron Lerisetron Memantine Ondansetron Palonosetron Ramosetron Renzapride Ricasetron Tedatioxetine Tetracyclic antidepressants (e.g.,amoxapine ,mianserin ,mirtazapine )Thujone Tropanserin Tropisetron Typical antipsychotics (e.g.,loxapine )Volatiles/gases (e.g.,nitrous oxide ,sevoflurane ,xenon )Vortioxetine Zacopride Zatosetron
5-HT4
5-HT5A
5-HT6
Agonists: Ergolines (e.g.,dihydroergocryptine ,dihydroergotamine ,ergotamine ,lisuride ,LSD ,mesulergine ,metergoline ,methysergide )Hypidone Serotonin (5-HT) Tryptamines (e.g.,2-Me-5-HT ,5-BT ,5-CT ,5-MT ,Bufotenin ,E-6801 ,E-6837 ,EMD-386088 ,EMDT ,LY-586713 ,N-Me-5-HT ,ST-1936 ,tryptamine )WAY-181187 WAY-208466 Antagonists: ABT-354 Atypical antipsychotics (e.g.,aripiprazole ,asenapine ,clorotepine ,clozapine ,fluperlapine ,iloperidone ,olanzapine ,tiospirone )AVN-101 AVN-211 AVN-322 AVN-397 BGC20-760 BVT-5182 BVT-74316 Cerlapirdine EGIS-12233 GW-742457 Idalopirdine Ketanserin Landipirdine Latrepirdine (dimebolin) Masupirdine Metitepine (methiothepin) MS-245 PRX-07034 PZKKN-94 Ritanserin Ro 04-6790 Ro 63-0563 SB-258585 SB-271046 SB-357134 SB-399885 SB-742457 Tetracyclic antidepressants (e.g.,amoxapine ,mianserin )Tricyclic antidepressants (e.g.,amitriptyline ,clomipramine ,doxepin ,nortriptyline )Typical antipsychotics (e.g.,chlorpromazine ,loxapine )
5-HT7
Antagonists: Atypical antipsychotics (e.g.,amisulpride ,aripiprazole ,asenapine ,brexpiprazole ,clorotepine ,clozapine ,fluperlapine ,olanzapine ,risperidone ,sertindole ,tiospirone ,ziprasidone ,zotepine )Butaclamol DR-4485 EGIS-12233 Ergolines (e.g.,2-Br-LSD (BOL-148) ,amesergide ,bromocriptine ,cabergoline ,dihydroergotamine ,ergotamine ,LY-53857 ,LY-215840 ,mesulergine ,metergoline ,methysergide ,sergolexole )JNJ-18038683 Ketanserin LY-215840 Metitepine (methiothepin) Ritanserin SB-258719 SB-258741 SB-269970 SB-656104 SB-656104A SB-691673 SLV-313 SLV-314 Spiperone SSR-181507 Tetracyclic antidepressants (e.g.,amoxapine ,maprotiline ,mianserin ,mirtazapine )Tricyclic antidepressants (e.g.,amitriptyline ,clomipramine ,imipramine )Typical antipsychotics (e.g.,acetophenazine ,chlorpromazine ,chlorprothixene ,fluphenazine ,loxapine ,pimozide )Vortioxetine
Phenethylamines Amphetamines Phentermines Cathinones Phenylisobutylamines (and further-extended) Catecholamines (and close relatives) Cyclized phenethylamines
Phenylalkylpyrrolidines 2-Benzylpiperidines (phenidates ) Phenylmorpholines (phenmetrazines) Phenyloxazolamines (aminorexes) Isoquinolines andtetrahydroisoquinolines 2-Aminoindanes 2-Aminotetralins Others / unsorted 1-Aminomethylindanes (e.g.,2CB-Ind ,AMMI ,bromojimscaline ,jimscaline )2-ADN 2-Benzhydrylpyrrolidine 2C-B-5-hemiFLY-α6 (BNAP) 2C-B-PYR 2CBecca 2CB7 2CJP 2CLisaB 2CLisaH 3-Benzazepines (e.g.,fenoldopam ,lorcaserin ,7-chlorolorcaserin ,SCHEMBL5334361 )3-Benzhydrylmorpholine 3-Phenylpiperidines (e.g.,3-phenylpiperidine ,3-PPP ,OSU-6162 (PNU-96391) ,LPH-5 ,LPH-48 ,Z3517967757 (Z7757) )6-AB AL-1095 Aminochromes (e.g.,adrenochrome ,adrenolutin )Benzocyclobutenes (e.g.,2CBCB-NBOMe ,bromotomscaline ,S33005 ,TCB-2 ,tomscaline )Benzoxepins (e.g.,BBOX ,IBOX ,TFMBOX )Butyltolylquinuclidine Camfetamine Cypenamine (trans -2-phenylcyclopentylamine) Diphenidine Diphenylprolinol DMBMPP Ergolines (e.g.,LSD )Fencamfamin GYKI-52895 HDMP-29 Ivabradine Methoxphenidine Methylmorphenate Milnacipran MT-45 2-Naphthylamine Org 6582 Partial ergolines (e.g.,NDTDI ,RU-27849 ,DEIMDHPCA ,DEMPDHPCA ,DEMPDHPCA-2C-D ,RU-27251 )PF-592,379 Phenylcyclopropylamines (e.g.,DMCPA ,TMT ,tranylcypromine )Phenylpiracetams (e.g.,phenylpiracetam ,MRZ-9547 ,RGPU-95 )Pyridopyrroloquinoxalines (e.g.,lumateperone ,deulumateperone ,IHCH-7079 ,IHCH-7086 ,IHCH-7113 ,ITI-1549 )Tetrahydrobenzopyranylamines (e.g.,CT-5126 )Tolazoline Tricyclics (e.g.,AMDA ,AMDH ,benzoctamine ,dizocilpine ,SpAMDA )ZC-B
Related compounds 2-Furylethylamine 2-Pyrrolylethylamine 3-Pyrrolylethylamine 3-Pyrrolylpropylamine 2-Tetrahydrofurylethylamine 4-Benzylpiperidine 7-AB Alkylamines (e.g.,1,3-DMBA Tooltip 1,3-dimethylbutylamine ,1,4-DMAA Tooltip 1,4-dimethylamylamine ,heptaminol ,iproheptine ,isometheptene ,methylhexanamine/ 1,3-DMAA ,octodrine ,oenethyl ,tuaminoheptane )Benzylamines (e.g.,benzylamine ,α-methylbenzylamine ,MDM1EA ,ALPHA ,M-ALPHA ,pargyline )Benzylpiperazines (e.g.,benzylpiperazine ,MDBZP ,fipexide )Cyclohexylaminopropanes (e.g.,propylhexedrine ,norpropylhexedrine )Cyclopentylaminopropanes (e.g.,isocyclamine ,cyclopentamine )Phenoxyethylamines (e.g.,3,4,5-trimethoxyphenoxyethylamine ,CT-4719 ,ORG-37684 )Phenylalkenylamines (e.g.,phenylbutenamine )Phenylalkynylamines (e.g.,phenylbutynamine )Phenylpiperazines (e.g.,1-phenylpiperazine ,mCPP Tooltip meta-chlorophenylpiperazine ,TFMPP Tooltip trifluoromethylphenylpiperazine ,oMPP Tooltip ortho-methylphenylpiperazine ,pFPP Tooltip para-fluorophenylpiperazine ,pMeOPP Tooltip para-methoxyphenylpiperazine )Phenylpropylamines (e.g.,phenylpropylamine ,homo-MDA ,homo-MDMA )Thienylaminopropanes (thiopropamines) (e.g.,thiopropamine ,methiopropamine ,thiothinone )